Drawing for HOMEOSEVENE

USPTO serial 79028544

HOMEOSEVENE

Reviewed by CopyMark Law Group

Reg. 3324878Status 404
Filing date
Status date
Registration date
Oct 30, 2007
Examiner
BEVERLY, JOSETTE MICHELLE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HOMEOSEVENE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations namely over the counter and prescription preparations for the prevention and treatment of diseases and disorders of the respiratory system, circulatory system, digestive system, urogenital system, and nervous system; sanitary preparations for medical purposes; sanitary preparations for medical use; dietetic substances adapted for medical use, namely food, herb teas and drinks; food for babies; herb teas for medicinal purposesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 10, 2016DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Nov 10, 2016DETHDEATH OF INTERNATIONAL REGISTRATION—
Jul 11, 2015INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jun 24, 2015INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jun 24, 2015INPCINVALIDATION PROCESSED—
Feb 6, 2015INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jun 6, 2014C71TCANCELLED SECTION 71—
May 28, 2009NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 14, 2008FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 5, 2008FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 5, 2008FIMPFINAL DISPOSITION PROCESSED—
Jan 30, 2008FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 30, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 14, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 25, 2007NPUBNOTICE OF PUBLICATION—
Jul 11, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 11, 2007ALIEASSIGNED TO LIE—
Jun 6, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 2, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 2, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 2, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 17, 2006RFNTREFUSAL PROCESSED BY IB—
Nov 1, 2006RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 1, 2006RFRRREFUSAL PROCESSED BY MPU—
Oct 29, 2006RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 28, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 20, 2006DOCKASSIGNED TO EXAMINER—
Oct 20, 2006NWAPNEW APPLICATION ENTERED—
Oct 19, 2006REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance